Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

NCT04748601 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

DRUG: Qudexy XR
DRUG: Placebo

Sponsor

Upsher-Smith Laboratories